Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie S Ryan

Showing results (11-20 of 91) with videos related to

Pageof 10
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2024
Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysisJonathan McLaughlin, William J Scotton, Natalie S Ryan, et al.
Alzheimer'S Research & Therapy|January 27, 2015
Imaging endpoints for clinical trials in Alzheimer's diseaseDavid M Cash, Jonathan D Rohrer, Natalie S Ryan, et al.
Journal of Alzheimer'S Disease : JAD|November 20, 2014
Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's diseaseNatalie S Ryan, Tammaryn Lashley, Tamas Revesz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 27, 2026
Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's diseaseClíona Farrell, Fedal Saini, Mona M Beidas, et al.
Brain Pathology (Zurich, Switzerland)|July 28, 2021
Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's diseaseNanet Willumsen, Teresa Poole, Jennifer M Nicholas, et al.
Alzheimer'S Research & Therapy|July 3, 2015
Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegenerationPhilip S J Weston, Ivor J A Simpson, Natalie S Ryan, et al.
Neurobiology of Aging|April 20, 2020
CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's diseasePhoebe Walsh, Carole H Sudre, Cassidy M Fiford, et al.
Journal of Alzheimer'S Disease : JAD|December 30, 2019
Clinical Association of White Matter Hyperintensities Localization in a Mexican Family with Spastic Paraparesis Carrying the PSEN1 A431E MutationRosalía A Santos-Mandujano, Natalie S Ryan, Lucía Chávez-Gutiérrez, et al.
Neurobiology of Aging|October 18, 2020
The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's diseasePhoebe Walsh, Carole H Sudre, Cassidy M Fiford, et al.
Neurology. Genetics|November 23, 2020
Disease duration in autosomal dominant familial Alzheimer disease: A survival analysisIvanna M Pavisic, Jennifer M Nicholas, Antoinette O'Connor, et al.
Pageof 10

Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 23, 2024
Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysisJonathan McLaughlin, William J Scotton, Natalie S Ryan, et al.
Alzheimer'S Research & Therapy|January 27, 2015
Imaging endpoints for clinical trials in Alzheimer's diseaseDavid M Cash, Jonathan D Rohrer, Natalie S Ryan, et al.
Journal of Alzheimer'S Disease : JAD|November 20, 2014
Spontaneous ARIA (amyloid-related imaging abnormalities) and cerebral amyloid angiopathy related inflammation in presenilin 1-associated familial Alzheimer's diseaseNatalie S Ryan, Tammaryn Lashley, Tamas Revesz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 27, 2026
Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's diseaseClíona Farrell, Fedal Saini, Mona M Beidas, et al.
Brain Pathology (Zurich, Switzerland)|July 28, 2021
Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's diseaseNanet Willumsen, Teresa Poole, Jennifer M Nicholas, et al.
Alzheimer'S Research & Therapy|July 3, 2015
Diffusion imaging changes in grey matter in Alzheimer's disease: a potential marker of early neurodegenerationPhilip S J Weston, Ivor J A Simpson, Natalie S Ryan, et al.
Neurobiology of Aging|April 20, 2020
CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's diseasePhoebe Walsh, Carole H Sudre, Cassidy M Fiford, et al.
Journal of Alzheimer'S Disease : JAD|December 30, 2019
Clinical Association of White Matter Hyperintensities Localization in a Mexican Family with Spastic Paraparesis Carrying the PSEN1 A431E MutationRosalía A Santos-Mandujano, Natalie S Ryan, Lucía Chávez-Gutiérrez, et al.
Neurobiology of Aging|October 18, 2020
The age-dependent associations of white matter hyperintensities and neurofilament light in early- and late-stage Alzheimer's diseasePhoebe Walsh, Carole H Sudre, Cassidy M Fiford, et al.
Neurology. Genetics|November 23, 2020
Disease duration in autosomal dominant familial Alzheimer disease: A survival analysisIvanna M Pavisic, Jennifer M Nicholas, Antoinette O'Connor, et al.
Pageof 10